Literature DB >> 28160452

Nanoescapology: progress toward understanding the endosomal escape of polymeric nanoparticles.

Laura I Selby1, Christina M Cortez-Jugo1,2,3, Georgina K Such4, Angus P R Johnston1,2.   

Abstract

Using nanoparticles to deliver drugs to cells has the potential to revolutionize the treatment of many diseases, including HIV, cancer, and diabetes. One of the major challenges facing this field is controlling where the drug is trafficked once the nanoparticle is taken up into the cell. In particular, if drugs remain localized in an endosomal or lysosomal compartment, the therapeutic can be rendered completely ineffective. To ensure the design of more effective delivery systems we must first develop a better understanding of how nanoparticles and their cargo are trafficked inside cells. This needs to be combined with an understanding of what characteristics are required for nanoparticles to achieve endosomal escape, along with methods to detect endosomal escape effectively. This review is focused into three sections: first, an introduction to the mechanisms governing internalization and trafficking in cells, second, a discussion of methods to detect endosomal escape, and finally, recent advances in controlling endosomal escape from polymer- and lipid-based nanoparticles, with a focus on engineering materials to promote endosomal escape. WIREs Nanomed Nanobiotechnol 2017, 9:e1452. doi: 10.1002/wnan.1452 For further resources related to this article, please visit the WIREs website.
© 2017 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28160452     DOI: 10.1002/wnan.1452

Source DB:  PubMed          Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol        ISSN: 1939-0041


  49 in total

1.  PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy.

Authors:  Fereydoon Abedi-Gaballu; Gholamreza Dehghan; Maryam Ghaffari; Reza Yekta; Soheil Abbaspour-Ravasjani; Behzad Baradaran; Jafar Ezzati Nazhad Dolatabadi; Michael R Hamblin
Journal:  Appl Mater Today       Date:  2018-05-29

Review 2.  Modulating the immune system through nanotechnology.

Authors:  Tamara G Dacoba; Ana Olivera; Dolores Torres; José Crecente-Campo; María José Alonso
Journal:  Semin Immunol       Date:  2017-10-09       Impact factor: 11.130

Review 3.  Overcoming Endosomal Entrapment in Drug Delivery.

Authors:  Dehua Pei; Marina Buyanova
Journal:  Bioconjug Chem       Date:  2018-12-19       Impact factor: 4.774

Review 4.  T-cell targeted pulmonary siRNA delivery for the treatment of asthma.

Authors:  Tobias W M Keil; Domizia Baldassi; Olivia M Merkel
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2020-04-08

5.  Design strategies for chemical-stimuli-responsive programmable nanotherapeutics.

Authors:  Muhammad Gulfam; Fitsum Feleke Sahle; Tao L Lowe
Journal:  Drug Discov Today       Date:  2018-10-05       Impact factor: 7.851

Review 6.  Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications.

Authors:  Christopher D Spicer; Coline Jumeaux; Bakul Gupta; Molly M Stevens
Journal:  Chem Soc Rev       Date:  2018-05-21       Impact factor: 54.564

Review 7.  Nanoparticle Delivery Systems with Cell-Specific Targeting for Pulmonary Diseases.

Authors:  Zicheng Deng; Gregory T Kalin; Donglu Shi; Vladimir V Kalinichenko
Journal:  Am J Respir Cell Mol Biol       Date:  2021-03       Impact factor: 6.914

Review 8.  Opportunities for Innovation: Building on the success of lipid nanoparticle vaccines.

Authors:  Jessica Huang; Daniel Yuen; Justine D Mintern; Angus P R Johnston
Journal:  Curr Opin Colloid Interface Sci       Date:  2021-05-29       Impact factor: 6.448

9.  Unravelling cytosolic delivery of cell penetrating peptides with a quantitative endosomal escape assay.

Authors:  Serena L Y Teo; Joshua J Rennick; Daniel Yuen; Hareth Al-Wassiti; Angus P R Johnston; Colin W Pouton
Journal:  Nat Commun       Date:  2021-06-17       Impact factor: 14.919

10.  Multifunctional magnetite nanoparticles to enable delivery of siRNA for the potential treatment of Alzheimer's.

Authors:  Natalia Lopez-Barbosa; Juan G Garcia; Javier Cifuentes; Lina M Castro; Felipe Vargas; Carlos Ostos; Gloria P Cardona-Gomez; Alher Mauricio Hernandez; Juan C Cruz
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.